The North America Fabry Disease Treatment Market is poised for robust growth over the forecast period from 2025 to 2032, driven by advancements in enzyme replacement therapy, increased awareness of rare genetic disorders, and expanding diagnostic capabilities. Fabry disease is a rare, inherited lysosomal storage disorder caused by the deficiency or malfunction of the alpha-galactosidase A...
Greek 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)